Most of us know Someone who is Struggling to Keep their Memory
If you have a relative, close friend or colleague who you know is worried about early problems with their memory, you will be interested to know about the latest global clinical trials into new drug treatments.
Re:Cognition Health, the UK medical group with expertise in memory and other cognitive (thinking) problems, is participating in the final stages of 4 separate global clinical trials for new medications for Alzheimer’s Disease and related conditions such as Fronto-Temporal Dementia and Mild Cognitive Impairment. The drugs in the studies are designed to halt the progression of memory loss. Re:Cognition are the only location in Greater London able to offer access to all 4 of these trials and are enrolling patients on an ongoing basis throughout 2013 and into 2014. These trials are free of charge.
How do you join a trial?
• You need to send an email as soon as possible to firstname.lastname@example.org to register for more information
• You will be contacted to check that you are eligible for one of the studies (you will need to have had your memory tested by a GP or specialist and may have had other tests as well)
Then you will be sent the Information Leaflet for the particular study. If you want to proceed, they will arrange an appointment for you to attend at a Centre to meet,
Why is this opportunity so important?
• Because memory problems are NOT a normal part of ageing. Everyone, of any age, can be forgetful occasionally, but on-going memory problems shouldn’t be ignored as early identification of the cause can improve the outlook in most cases
• Most importantly, for progressiveContinuously increasing in extent or severity. causes of memory loss, there are now new medications which can enhance memory and may even stop or reverse damage to the brain. These new medicines are not yet available from your GP, but can be accessed now through these clinical trials by people who have a diagnosisThe process of determining which condition a patient may have. that matches the criteria for one of the studies